What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Atrix
95%DGNews: FDA Approves Eligard 22.5mg (Leuprolide Acetate for Injectable Suspension), Three-Month Prostate Cancer Product
95%DGNews: FDA Approves Eligard 7.5 mg (Leuprolide) for Prostate Cancer
95%DGNews: Atrigel Successful In Decreasing Testosterone In Advanced Prostate Cancer
94%DGNews: Eligard (Leuprolide), Treatment for Prostate Cancer, Receives Marketing Authorization in Germany
94%DGNews: Atrisone (Dapsone Topical Gel) Effective for Treatment of Acne
94%DGNews: Monthly Leuprogel (Leuprolide) Suppresses Serum Testosterone In Advanced Prostate Cancer
94%DGNews: FDA Approves Atrisorb Tissue Regeneration Barrier With Doxycycline
91%DGNews: Eligard (Leuprolide Acetate) Prostate Cancer Products Approved in Canada
91%DGNews: FDA Approves Eligard 30mg (Leuprolide Acetate for Injectable Suspension), Four-Month Prostate Cancer Product
90%DGNews: FDA Approves Atridox Periodontal Disease Treatment
90%DGNews: Atridox Approved In Europe For Periodontal Disease
88%DGNews: Atridox Periodontal Disease Treatment Approved In Europe
86%DGNews: Atridox Therapy Now Available In U.S. For Periodontal Disease
85%DGNews: Atridox Effective For Chronic Adult Periodontitis
81%DGNews: Hormone Therapy With Innovative Delivery System Available For Prostate Cancer Eligard 7.5 mg (Leuprolide Acetate For Injectable Suspension)
78%DGNews: MediGene's Drug Eligard Launched in Spain and Further European Countries
75%DGNews: AAD: Topical Dapsone Gel Appears Safe and Effective in Long-Term Use Against Acne
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.